Mabsoft Therapeutics (Shanghai) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Mabsoft Therapeutics (Shanghai) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors (NCT07644650) | Mabsoft Therapeutics (Shanghai) Co., Ltd. | 2026-06-15 |
Track Mabsoft Therapeutics (Shanghai) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.